Politics

Tracking how politics and policy intersect with science and health care

The Maryland State Capitol Building
Politics

Pharma lobbyists flooded Maryland to block a drug-pricing bill. Opponents pushed back — and won

By Lev Facher

Anna Eshoo, Jan Schakowsky
Politics

‘I don’t know how you people sleep at night’: Visibly irate lawmakers blast pharma, PBMs over insulin prices

By Nicholas Florko

Alex Azar at STAT
Politics

‘He calls me, I call him’: Alex Azar on his relationship with President Trump, drug pricing, and winning over skeptical conservatives

By Lev Facher

Chuck Grassley (R-IA) walks to a vote
Politics

PBMs sidestep the Senate’s tough questions — but lawmakers hint at legislation

By Nicholas Florko

Senate Hearing
Politics

Today, five pharmacy ‘middlemen’ head to Capitol Hill’s hot seat. Here’s what you need to know

By Nicholas Florko

FDA Heroin Spoon Sculpture
Politics

Protesters’ goodbye for Scott Gottlieb: a supersized heroin spoon and claims FDA did too little on opioids

By Lev Facher

Richard Neal
Politics

Powerful House committee to weigh legislation aimed at shedding more light on high drug prices

By Nicholas Florko

digital community center
Health

Digital health startups want to help Medicare prevent diabetes, if only it will let them

By Casey Ross

Teen Juul
Health

FDA is investigating reports of seizures after vaping

By Megan Thielking

AI FDA concept illo
Politics

FDA developing new rules for artificial intelligence in medicine

By Casey Ross

Colorful selection of pills
Politics

Coalition attacks Trump plan to end drug rebates, calling it a ‘big pharma bailout’

By Nicholas Florko

CRISPR for congress
Politics

The mark of a job well done for a CRISPR lobbyist? Silence in Congress

By Nicholas Florko

Donald Trump - improving free inquiry, transparency, and accountability
Politics

Will Trump’s new free speech order affect research funding?

By Lev Facher

Rep. Elijah Cummings
Politics

House Democrats request Purdue opioid documents, focusing on the role of the Sacklers

By Andrew Joseph

Pharma needs new Prescription
Politics

Mystery solved: the pharma-backed group with a lot to say on Trump’s pitch to end drug rebates

By Nicholas Florko

FDA Securities Fraud
Politics

Julie Dohm, FDA’s top compounding official, set to leave agency

By Nicholas Florko

Prescription Medication
Politics

A drug pricing mystery: Who’s behind all the outrage over rebates?

By Nicholas Florko

The capitol at sunrise
Politics

Powerful Medicare advisory group criticizes Congress for ‘donut hole’ changes

By Nicholas Florko

VASOSTRICT illo
Politics

An ICU staple has exponentially spiked in price. Can compounding solve that problem? Now the courts will decide

By Nicholas Florko

Norman E. Sharpless
Politics

A believer in biotech and big data: How Ned Sharpless vaulted to the top of the FDA

By Lev Facher and Kate Sheridan

He Jiankui arrives to speak
In the Lab

Leading scientists, backed by NIH, call for a global moratorium on creating ‘CRISPR babies’

By Sharon Begley

Ron Wyden
Pharmalot

Wyden probes a patient advocacy group over its ties to opioid makers

By Ed Silverman

Sen. Chuck Grassley (R-IA)
Politics

Key senators call five pharmacy middlemen to testify about drug prices

By Nicholas Florko

Norman E. Sharpless
Politics

Ned Sharpless, director of the National Cancer Institute, to be named acting FDA commissioner

By Lev Facher

Donald Trump speaks prior to signing bills intended to lower prescription drug prices
Politics

Trump budget pitches capping seniors’ out-of-pocket drug costs, cutting NIH funding

By Lev Facher

Fenway Park
Politics

How do you improve Medicare? Maybe you watch Major League Baseball

By Nicholas Florko

Vials
Pharmalot

What’s in a name? FDA changes course for biosimilar names and upsets generic makers

By Ed Silverman

Title Devin Nunes
Politics

GOP lawmakers lambaste Democratic push to strip patents from drug companies

By Lev Facher

Earth's City Lights at Night
The Pharmalot View

Forget about an international pricing index for drugs. Cost-effectiveness is a better bargain

By Ed Silverman

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy